Accessibility settings

This paper is in the following e-collection/theme issue:

Drug Repurposing and Off-Label Use (31) Public (e)Health, Digital Epidemiology and Public Health Informatics (1130) Data Science (397)

Published on in Vol 4 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/37306, first published .
The Identification of Potential Drugs for Dengue Hemorrhagic Fever: Network-Based Drug Reprofiling Study

The Identification of Potential Drugs for Dengue Hemorrhagic Fever: Network-Based Drug Reprofiling Study

The Identification of Potential Drugs for Dengue Hemorrhagic Fever: Network-Based Drug Reprofiling Study

Authors of this article:

Praveenkumar Kochuthakidiyel Suresh1 Author Orcid Image ;   Gnanasoundari Sekar2 Author Orcid Image ;   Kavya Mallady3 Author Orcid Image ;   Wan Suriana Wan Ab Rahman4 Author Orcid Image ;   Wan Nazatul Shima Shahidan4 Author Orcid Image ;   Gokulakannan Venkatesan4 Author Orcid Image
Article Authors Cited by (4) Tweetations (5) Metrics

Journals

  1. Eng S, Frishman W, Aronow W. Cardiovascular Complications of Dengue Virus. Cardiology in Review 2025 View
  2. Bourgeois N, Wei L, Kaushansky A, Aitchison J. Exploiting host kinases to combat dengue virus infection and disease. Antiviral Research 2025;241:106172 View
  3. Malekzadeh S, Ayatollahi H, Toni E. Mobile‐Based Medication Management Applications: A Scoping Review of Functional and Non‐Functional Requirements. Healthcare Technology Letters 2026;13(1) View
  4. Chutia D, Borah K, Singh L, Sarmah D, Singha L. Updates on dengue virus infection: Epidemiology, molecular pathogenesis, and clinical strategies. Vacunas 2026;27(3):500652 View